UAB "Centralpharma Communications" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
137,000 |
68,500 |
1,555 |
1,477 |
739 |
0.16 |
0.07 |
59.89 |
1.08 |
21,997 |
1,594 |
350 |
23,241 |
2022 |
---|
125,000 |
50,201 |
1,589 |
1,509 |
606 |
0.18 |
0.12 |
76.95 |
1.21 |
23,506 |
2,837 |
220 |
25,597 |
2023 |
---|
121,500 |
40,500 |
1,073 |
1,019 |
340 |
0.20 |
0.11 |
89.01 |
0.84 |
24,525 |
2,651 |
89 |
26,878 |
Register and
explore Okredo data2023 |
---|
121,500 |
40,500 |
1,073 |
1,019 |
340 |
0.20 |
0.11 |
89.01 |
0.84 |
24,525 |
2,651 |
89 |
26,878 |
Register and
explore Okredo data2023
Turnover (€)
121,500 €-3 % *
Sales per employee (€)
40,500 €-19 % *
Profit before tax (€)
1,073 €-32 % *
Net Profit (€)
1,019 €-32 % *
Profit per employee (€)
340 €-44 % *
Working capital requirement
0.20 11.11 % *
Debt-to-equity ratio
0.11 -8.33 % *
Total profitability (%)
89.01 %15.67 % *
Net profitability (%)
0.84 %-30.58 % *
Equity (€)
24,525 €4 % *
Amounts Payable And Liabilities (€)
2,651 €-7 % *
Non-current Assets (€)
89 €-60 % *
CurrentAssets (€)
26,878 €5 % *